Abstract. A Monte Carlo simulation was applied to study the energy dependence on the transverse dose distribution of microplanar beam radiation therapy (MRT) for deep-seated tumors. The distribution was found to be the peak (in-beam) dose and the decay from the edge of the beam down to the valley. The area below the same valley dose level (valley region) was decreased with the increase in the energy of X-rays at the same beam separation. To optimize the MRT, we made the following two assumptions: the therapeutic gain may be attributed to the efficient recovery of normal tissue caused by the beam separation; and a key factor for the efficient recovery of normal tissue depends on the area size of the valley region. Based on these assumptions and the results of the simulated dose distribution, we concluded that the optimum X-ray energy was in the range of 100-300 keV depending on the effective peak dose to the target tumors and/or tolerable surface dose. In addition, we proposed parameters to be studied for the optimization of MRT to deep-seated tumors.
Introduction
Microplanar beam radiation therapy (MRT) [1, 2] is based on earlier findings that tissue that has had damage induced by a narrow beam of radiation recovers more efficiently than when damage is induced by a broad beam [3, 4] . Slatkin et al. [5] proposed an MRT to treat brain tumors and confirmed that normal tissue has extremely high tolerance to microplanar beam X-rays [6] . Laissue et al. [7] demonstrated that MRT is effective in increasing the life span of rats bearing brain tumors, and since then, many results for synchrotron radiation have been accumulated with regards to its sparing effects on normal tissue [8] [9] [10] [11] [12] and therapeutic effects in tumor bearing animals [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] .
MRT is a spatially fractionated radiation therapy with parallel beams of mainly 25-50 µm beam width and 100-500 µm center-to-center separation, at a peak dose of 100-600 (usually 300) Gy from one direction or orthogonally arranged multiple directions of a single shot from each direction. Animal studies have been performed with synchrotron radiation with a mean energy of approximately 100 keV or less.
However, to apply this method to human therapy, higher X-ray energies than those used in animal studies are preferred, because human tumors are often deep-seated, such that external low-energy X-rays are markedly decreased and the radiation effects on normal tissues in front of the tumors may become serious before delivery of the therapeutic dose. Prezado et al. [24] found that the energy to optimize the peak-to-valley ratio is 375 keV in a mini-beam radiation therapy. However, as for spatially fractionated radiation therapy, a narrow microbeam is more effective than a wide beam [22] . In the current work, we applied a Monte Carlo simulation to study the dose distribution of MRT with respect to X-ray energy and proposed an optimized MRT for deep-seated tumors.
Methods

Evaluation of transverse dose distribution
The PENELOPE code [25] was used for a Monte Carlo simulation of the estimation of the transverse dose distribution profile for the following three types of X-ray beams: (1) non-divergent X-rays with a cross section of 1 mm × 20 µm (directions Y × X, see Fig. 1 ) or 1 mm × 50 µm; (2) non-divergent X-rays with a cross section of 1 mm × 1 mm in coming on a 50 µm-wide single-slit collimator defining Figure 1 illustrates the simulation arrangements. In this work, uniform distribution of the beam is assumed and the number of primary photon was ∼ 2 × 10 9 in all of the calculations.
Assumptions for the analysis of transverse dose distribution profile
To analyze the simulation results, we made the following assumptions: the therapeutic gain may be attributed to the efficient recovery of normal tissue caused by the beam separation and a key factor in the efficient recovery of normal tissue depends on the area size of the valley region. Figure 2 illustrates the separation of area proposed for the analysis of the MRT. The transverse dose profile is divided into three regions: the P-zone for the peak dose region corresponding to beam path, the V-zone for the valley dose region of absorbed dose below 6 Gy, and the I-zone for the area between the P-and V-zones. transverse dose distribution was found when the absorbed dose was estimated with the water phantom positioned at the entrance, at 10 cm in depth, and at 10 cm in depth after passing through an air layer of 100 cm (Figs 3a to 3d ). In addition, the distribution was independent of the presence of the tungsten slit (Figs 3e and 3f) . However, when the X-ray beam was conical, the transverse distribution became broader (Figs 3e to 3g) and the width of the beam increased as the distance from the exit of tungsten slit increased (Fig. 3g) .
Results
Comparison of the transverse dose distribution
To study the transverse dose distribution profile for five beams of 50 µm wide and 500 µm separation, ± 2 mm wide profile is required. Since PENELOPE code is limited to ± 1 mm wide profile for 20 µm step distribution, wide range dose distribution was obtained as follows: one-side distribution from the beam center to 2 mm was calculated, then reversed it as for the reverse-side distribution from center to −2 mm, and integrated each other. In Fig. 4 , this distribution profile for 1 MeV X-rays was compared with the directly calculated dose distribution of non-divergent X-rays. It was confirmed that the estimation of wide-range distribution was possible by this integration method. Figure 5 shows the transverse dose distribution from the side boundary of the beam edge. The distribution was not affected by beam width (20 µm or 50 µm) even for the conical beam. However, when the X-ray energy was 100 keV, a slight increase in the absorbed dose was found for the 50 µm beam width.
Effect of the beam width on the transverse distribution
X-ray Energy dependence on the transverse dose distribution
The energy dependence of the transverse dose distribution was estimated from the data between the center and a position at 2 mm from the center, by integrating the results to create a full profile as shown in Fig. 4 . The integrated dose distributions were overlapped by shifting the beam center by 500 µm to create 9 parallel beams of 50 µm width with a 500 µm center-to-center separation. Figure 6 shows the central portion of the results from −300 µm and +700 µm. One of the characteristics of MRT is the level of the valley dose. Figure 6 shows that the valley dose and the dose in the I-zone increased with increasing X-ray energy. This increase was remarkable at the energy higher than 300 keV probably due to the increased range of scattered X-rays and/or secondary X-rays and electrons. In contrast, it should be noted that relative valley dose was higher at 50 keV X-rays than those at higher energy X-rays. This may be attributed to the small range of scattered X-rays and/or secondary X-rays in the case of 50 keV X-rays, at which the energy may be effectively deposited in the range of valley region. 
X-ray energy dependence of the absorbed dose at various depths in water
The absorbed dose decreases as the depth of the tumor from the surface increases. Figure 7 shows the X-ray energy dependence of the absorbed dose at various water depths. This decrease in the absorbed dose should be taken into account when MRT is applied to deep-seated tumors.
Determination of I-and V-zone widths from the experimental results
The sizes of the I-and V-zones in Fig. 2 were determined based on the experimental results of Kondoh et al. [26] , in which Wistar rats bearing C6 glioma in the brain were irradiated with two orthogonal X-ray arrays at a peak dose of ∼ 300 Gy (25 µm beam width and 200 µm center-to-center beam separation). In their results, a remarkable increase in life span was observed with a median survival time of 51 days for treated rats, compared with 21 days for untreated rats. The dose distribution profile for the experiments was reported by Nariyama et al. [27] . Table 1 shows the values for each zone in Fig. 2 , as estimated from the measured values in figure 6 in the report [27] , based on the peak dose and beam width were 300 Gy and 25 µm, respectively and assumed that the dose in the valley region was 6 Gy for the recovery of normal tissue. Fig. 7 . Target was placed at a depth of 10 cm in water. Table 3 X-ray energy dependence of the peak dose at the target, I-zone width and beam separation when the peak dose at the surface is 300 Gy Table 2 . I-zone width was estimated from Fig. 6 as the distance between the beam edge and the point of absorption of 6 Gy in the surface. Difference in I-zone between the beam width of 20 µm and 50 µm was ignored. P-zone width: beam width. V-zone width: 80 µm. Beam separation = P-zone width + 2 × I-zone width + V-zone width. Target was placed at a depth of 10 cm in water. Table 2 . I-zone width was estimated from Fig. 6 as the distance between the beam edge and the point of absorption of 6 Gy on the surface. Difference in I-zone between the beam width of 20 µm and 50 µm was ignored. P-zone width: beam width. V-zone width: 80 µm. Beam separation = P-zone width + 2 × I-zone width + V-zone width. Target was placed at a depth of 10 cm in water. Table 2 shows the numerical data of Fig. 7 for the energy dependence of the absorbed dose relative to the surface when the tumor is present at a depth of 10 cm from the surface. When the peak dose at the surface is 300 Gy, 10 MeV X-rays are required for the delivery of ∼ 300 Gy (105.8%) onto the tumor. At an X-ray energy of 250 keV, only ∼ 85 Gy (28.3%) will be delivered to the tumor. If we maintain a peak dose of 300 Gy at the tumor located at a 10 cm depth, the peak dose at the surface must be increased to more than 1000 (= 300/0.299) Gy with an X-ray energy of 275 keV. The data in Table 2 were used for the calculation of absorbed dose in Tables 3 and 4.  Tables 3 and 4 show the energy dependence of the estimated peak dose, I-zone width, and beam separation, at a beam width of 20 µm or 50 µm and a peak dose of 300 Gy. Table 3 shows these parameters at the surface and Table 4 shows these parameters at a tumor site at a depth of 10 cm in water based on the V-zone (absorbed dose 6 Gy at the surface) width to be 80 µm. When the peak dose at the surface is set to 300 Gy, the dose delivered to the tumor at a depth of 10 cm from the surface is calculated to be less than 100 Gy for an X-ray energy below 300 keV (Table 3 ). In contrast, if MRT requires a peak dose of 300 Gy at the tumor, the dose at the surface must be as high as 1000 Gy at an X-ray energy of 300 keV (Table 4) and 1250 Gy at an energy between 100 and 200 keV. Since Slatkin et al. [6] demonstrated that brain tissue is apparently normal in all cases at an in-beam skin dose of 625 Gy for MRT and in most cases at 1250 Gy, the tolerable level of skin-entrance dose is probably in the range of 625-1250 Gy. In addition, the required peak dose for the treatment could be less than 300 Gy, although the optimum peak dose remains to be studied.
X-ray dose for MRT to the deep-seated tumors in various X-ray energies
Thus, in combination with the results indicated in Section 3.3, we conclude that the optimum energy for MRT is in the range of 100-300 keV. The results indicate that the tolerable surface dose must be determined for the successful treatment of MRT for deep-seated tumors.
Discussion
Rational for the V-zone to be 6 Gy
Since one of the characteristic advantages of MRT over conventional radiation therapy may be in the efficient recovery rate of normal tissue, resulting in highly selective killing of tumor cells, we based on the knowledge that the recovery of normal healthy tissue is a critical factor. Thus, we assumed a V-zone for the recovery of normal tissue and an absorbed dose in the V-zone of 6 Gy which is tolerable for normal skin to the acute effects of radiation [28] , although the upper limit for this value remains to be determined. Table 5 shows a summary of the reported results based on irradiation with two orthogonal or bidirectional beams. These results were obtained from animal studies in which tumors were seated close to the surface. In Table 5 , estimated values of beam separation according to the current assumptions are also included for the comparison. The beam separations in all reported successful experiments were smaller than the estimated values. The results suggest that either a valley dose greater than 6 Gy may be tolerable by normal tissue or the distance of the V-zone may be smaller than 80 µm. In addition, the results obtained by Laissue et al. [7] were the most effective for the treatment. The reason may be due to the low X-ray energy since in their case the mean energy was approximately 50 keV and 90% of the beam was in the range of 32 to 131 keV, while X-rays from other reports had a mean at the energy range of 90-100 keV and most were in the range of 50-350 keV. As shown in Fig. 6 , higher energy X-rays affect more to an increased range of I-zone. Therefore, the effective treatment by Laissue et al. [7] could be explained by the smaller I-zone and wider valley region compared with other experiments. Even in their case, the valley dose must be higher than 6 Gy because the beam separations in their experiments are smaller than the estimated value for 50 keV X-rays as shown in Table 5 . Based on these considerations, the current method was in good agreement with the experimental results for animal tumors seated close to the surface and is to be supported for the estimation of doses for deep seated tumors. These results give the very important knowledge for the precise evaluation of dose and the distance of the V-zone.
Importance of the present method
Parameter optimization for irradiation program
The following parameters remain to be clarified for the optimization of an irradiation program: (1) lower limit of peak dose, (2) upper limit of valley dose tolerable for normal tissue recovery, and (3) optimum V-zone distance. In addition, for the effective treatment, the tumors should not be moved during irradiation. For this purpose, intense, short pulsed X-rays are required. Since nerve motion is greater than 0.1 mm in one cardiac-cycle [29] , the required irradiation-time duration should be less than 1 ms such that movement of the tumors is limited to less than 10 µm, which keeps the structure of the microbeams at 20-50 µm in width. To fulfill this condition, an intense, pulsed X-ray source driven by a laser [30] [31] [32] or accelerator [33] [34] [35] may be a candidate for a future X-ray source along with synchrotron radiation.
Potential advantages of MRT
The mechanism for the selective killing of tumor cells should be attributed to the selective damage in the tumor vessels compared with those for normal tissue [36] [37] [38] [39] . This is completely different from the conventional treatment method which aims at the selective killing of tumor cells. Thus, potential advantages of an MRT over a conventional X-ray treatment method are: (1) Patient may obtain relief from a heavy treatment load, because the treatment is only administered once in two directions of irradiation, which is quite different from conventional radiation therapy; (2) Positioning the patient may be simpler because the treatment area can be decided easily as the area including the tumor site and is not as critical as in the conventional method; (3) Repeated treatments may be possible; and in addition, (4) The use of gold nanoparticles as an anti-angiogenic sensitizer [40] may be much more effective for the treatment by the dose enhancement on tumor capillary vessels. The rationale for the third advantage is as follows: recovered normal cells were exposed to a very low level of X-rays, since all of the in-beam (P-zone) cells and many of I-zone cells should be dead. Therefore, only a small fraction of the normal cells in the treated area would have memory of the X-ray exposure. In contrast, in the conventional method, most normal cells in the irradiated area would have X-ray exposures as high as the accumulated dose of the total treatment. Although these possibilities remain to be clarified by future animal studies, the current results strongly suggest the potential of MRT for human treatment.
